Nuclear NAD<sup>+</sup>-biosynthetic enzyme NMNAT1 facilitates development and early survival of retinal neurons.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34878972.
- Also identified by DOI 10.7554/eLife.71185 and PMC identifier 8754432.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Despite mounting evidence that the mammalian retina is exceptionally reliant on proper NAD<sup>+</sup> homeostasis for health and function, the specific roles of subcellular NAD<sup>+</sup> pools in retinal development, maintenance, and disease remain obscure. Here, we show that deletion of the nuclear-localized NAD<sup>+</sup> synthase nicotinamide mononucleotide adenylyltransferase-1 (NMNAT1) in the developing murine retina causes early and severe degeneration of photoreceptors and select inner retinal neurons via multiple distinct cell death pathways. This severe phenotype is associated with disruptions to retinal central carbon metabolism, purine nucleotide synthesis, and amino acid pathways. Furthermore, transcriptomic and immunostaining approaches reveal dysregulation of a collection of photoreceptor and synapse-specific genes in NMNAT1 knockout retinas prior to detectable morphological or metabolic alterations. Collectively, our study reveals previously unrecognized complexity in NMNAT1-associated retinal degeneration and suggests a yet-undescribed role for NMNAT1 in gene regulation during photoreceptor terminal differentiation.
Medical subject headings
- Gene Deletion
- Nicotinamide-Nucleotide Adenylyltransferase
- Photoreceptor Cells, Vertebrate
- Retinal Degeneration
- Retinal Neurons